O
Organon & Co.
OGN · NYSE · Healthcare · 3.6B
Price · close
$13.75
+0.07% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
19.1×
Price / net assetsP/B
4.7×
Enterprise value / EBITDAEV/EBITDA
9.2×
Free cash flow yieldFCF yield
15.1%
Return on equityROE
24.9%
Operating margin
20.7%
Net debt / EBITDAbalance-sheet strength
6.4×
Interest coverage
2.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.